Six years after the European Commission created the world's first bioeconomy strategy and action plan, it...
Up To Date
Latest News
T cells target a bacterial variant of a human enzyme promoting autoimmune diseases such as Multiple...
Genentech's new partner Affimed NV has halted two blood cancer programmes with its tetravalent bispecific T...
Oxford-based immunoncology player Sitryx Therapeutics Ltd. (Oxford, U.K.) has bagged $30m in a Series A...
British gene therapy developer Orchard Therapeutics will go IPO on Nasdaq, according to SEC filings. The...
Diagnostics company sphingotec GmbH successfully closed a €20m growth equity financing round led by...